AKAM
37
3
CHD
26
2
MCK
56
3
XRAY
28
3
GM
47
-3
KMI
79
2
MUR
38
3
ABT
57
3
GD
41
2
AEP
56
5
UNH
45
4
HIG
48
4
FTI
81
3
VMC
33
3
KSS
32
-2
AES
39
-2
FE
44
3
PAYX
44
6
DHI
35
4
WEC
48
7
AKAM
37
3
CHD
26
2
MCK
56
3
XRAY
28
3
GM
47
-3
KMI
79
2
MUR
38
3
ABT
57
3
GD
41
2
AEP
56
5
UNH
45
4
HIG
48
4
FTI
81
3
VMC
33
3
KSS
32
-2
AES
39
-2
FE
44
3
PAYX
44
6
DHI
35
4
WEC
48
7
Financhill
Back

Atara Biotherapeutics Stock Predictions

Free Stock Analysis Report: See The True Value of Any Stock

Analyze Any Stock Free
Buy
60

ATRA
Atara Biotherapeutics

Last Price:
$15.63
Seasonality Move:
5.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Free Stock Analysis Report: Get a clear concise Stock Rating

Analyze Any Stock Free

Atara Biotherapeutics Stock Forecast

  • Over the next 52 weeks, Atara Biotherapeutics has on average historically fallen by 14.3% based on the past 10 years of stock performance.
  • Atara Biotherapeutics has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Atara Biotherapeutics Stock Undervalued?
    The current Atara Biotherapeutics [ATRA] share price is $16.53. The Score for ATRA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ATRA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Atara Biotherapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Atara Biotherapeutics has on average historically fallen by 14.3% based on the past 10 years of stock performance.

Atara Biotherapeutics Stock Rating

Buy
60
Atara Biotherapeutics (ATRA) is a Buy

Is Atara Biotherapeutics overpriced?

  • Atara Biotherapeutics has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Atara Biotherapeutics Stock Price History

Is ATRA stock going to rise?

  • The current trend is moderately bullish and ATRA is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
atarabio.com

52-Week Data

52-Week High:
39.50
52-Week Low:
6.50

Prediction Charts

Market Cap:
90M
Price in USD:
16.53
Volume:
72.1K
Beta:
0.99

Technical Analysis

SMA50:
11.97
SMA100:
10.00
SMA200:
11.60
52-Wk Change:
19.14%

Stock Predictions

  • Is Atara Biotherapeutics stock public?
    Yes, Atara Biotherapeutics is a publicly traded company.
  • What is the Atara Biotherapeutics stock quote today?
    The Atara Biotherapeutics stock price is 16.53 USD today.
  • How to buy Atara Biotherapeutics stock online?
    You can buy Atara Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-18 10.35 9.94 10.60 9.68
Dec-19 10.01 9.93 10.37 9.13
Dec-20 10.43 11.40 11.47 9.86
Dec-23 11.55 12.20 12.45 11.36
Dec-24 12.37 13.33 13.39 12.16
Dec-26 13.59 12.98 13.98 12.59
Dec-27 12.90 12.15 12.90 11.76
Dec-30 12.07 13.28 13.90 11.75
Dec-31 13.40 13.31 13.59 12.61
Jan-2 13.34 14.16 14.85 13.28
Jan-3 14.49 16.35 18.70 14.49
Jan-6 17.00 18.00 18.71 16.36
Jan-7 18.10 16.85 18.42 16.34
Jan-8 16.90 16.53 17.01 15.50

Atara Biotherapeutics Earnings

Atara Biotherapeutics Earnings Report: Per Share Atara Biotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Atara Biotherapeutics Forecast Revenue Growth

Atara Biotherapeutics Stock Analysis: Historical quarterly revenues per share for Atara Biotherapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $11.80 per share, a decrease next quarter of $0.00 per share, a decrease this year of $10.45 per share, and an increase next year of $5.50 per share.

* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.